December 31, 2015: FemPulse Completes Financing
FemPulse completed a private financing round to support the company’s clinical, regulatory and R&D objectives. The round, which was oversubscribed, brought in experienced, value-add investors who are expected to contribute to the success of the company.
December 10, 2015: Dr. Haessler speaks at North American Neuromodulation Society Conference
FemPulse was invited to present during the I3 forum sponsored by the North American Neuromodulation Society. I3, representing Innovation, Investment and Invigoration, provides a fitting context for a presentation regarding this leading edge company. The FemPulse system is a first-of- its-kind wearable neuromodulation system providing discrete, simple and continuous neuromodulation therapy for OAB. Dr. Haessler […]
